SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-24-001845
Filing Date
2024-11-22
Accepted
2024-11-22 16:31:16
Documents
16
Period of Report
2024-11-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e6163_8-k.htm   iXBRL 8-K 32394
2 EXHIBIT 10.1 e6163_ex10-1.htm EX-10.1 20336
3 EXHIBIT 99.1 e6163_ex99-1.htm EX-99.1 9412
4 EXHIBIT 99.2 e6163_ex99-2.htm EX-99.2 9453
  Complete submission text file 0001731122-24-001845.txt   264897

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vrpx-20241119.xsd EX-101.SCH 3027
6 XBRL LABEL FILE vrpx-20241119_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE vrpx-20241119_pre.xml EX-101.PRE 24173
18 EXTRACTED XBRL INSTANCE DOCUMENT e6163_8-k_htm.xml XML 3806
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40064 | Film No.: 241490247
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)